8:29   Eli Lilly beats on Q2 revenue and profit driven by 'a collection' of name brand drug sales: Analyst 0:55   Eli Lilly beats on Q3 earnings, cites diabetes drug demand 0:50   Eli Lilly posts earnings beat and raises full year guidance 0:55   Eli Lilly posts EPS and revenue beat 2:05   Eli Lilly posts top and bottom line beats 1:03   Eli Lilly Beats Estimates, Boosts Guidance 1:32   Eli Lilly Beats the Street on Q2 Revenue (NYSE:LLY) 1:37   Eli Lilly Files Trademarks for COV-BEAT, COV-BLOCK & COV-BARRIER 10:47   Eli Lilly Beating The Market | Pharmaceutical Industry | Intrinsic Value Analysis 9:43   Eli Lilly CEO on quarterly earnings beat, pharma policy, and more 0:22   Eli Lilly & Co. and Anima Biotech win US Deal of the Year at Lifestars Awards 2018 0:18   How Eli Lilly CEO Beat the Competition by Freezing Insulin Prices 3:49   Eli Lilly beats on quarterly profit hikes full-year guidance on strong 4:23   Two bullish calls on Eli Lilly 1:50   Eli Lilly notches best week on record: how to trade the run 0:32   Pharmaceutical Company Eli Lilly Caps Out-of-Pocket Cost for Insulin at $35 7:33   Eli Lilly Stock Valuation --- $LLY 4:24   Eli Lilly price target raised by $300 to $1,025 by Deutsche Bank